MedPath

广东大冢制药有限公司

Ownership
-
Established
1993-06-01
Employees
-
Market Cap
-
Website
www.gdotsuka.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

48

NMPA:48

Drug Approvals

Procaterol Hydrochloride Oral Solution

Product Name
美普清
Approval Number
国药准字H20258002
Approval Date
Jan 6, 2025
NMPA

Compound Glucose / Electrolytes Irrigation Solution for Craniocerebral Surgery

Product Name
复方葡萄糖/电解质颅脑手术冲洗液
Approval Number
国药准字H20244897
Approval Date
Sep 19, 2024
NMPA

Electrolytes and Glucose Composition Injection R4A

Product Name
复方电解质葡萄糖注射液-R4A
Approval Number
国药准字H20227086
Approval Date
Jun 29, 2022
NMPA

Electrolytes and Glucose Composition Injection R4A

Product Name
复方电解质葡萄糖注射液-R4A
Approval Number
国药准字H20227084
Approval Date
Jun 28, 2022
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20227032
Approval Date
Mar 15, 2022
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20227031
Approval Date
Mar 15, 2022
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20227033
Approval Date
Mar 15, 2022
NMPA

Medium and Long Chain Fat Emulsion Injection(C8~24Ve)

Product Name
中/长链脂肪乳注射液(C8~24Ve)
Approval Number
国药准字H20213103
Approval Date
Feb 2, 2021
NMPA

Medium and Long Chain Fat Emulsion Injection(C8~24Ve)

Product Name
中/长链脂肪乳注射液(C8~24Ve)
Approval Number
国药准字H20213104
Approval Date
Feb 2, 2021
NMPA

Compound Sodium Lactate and Sorbitol Injection

Product Name
复方乳酸钠山梨醇注射液
Approval Number
国药准字H20205053
Approval Date
Dec 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.